Hendriks, Pim http://orcid.org/0000-0002-4992-9967
Rietbergen, Daphne D. D. http://orcid.org/0000-0001-9873-6179
van Erkel, Arian R. http://orcid.org/0000-0002-0298-2015
Coenraad, Minneke J. http://orcid.org/0000-0002-3434-4421
Arntz, Mark J. http://orcid.org/0000-0002-2402-7617
Bennink, Roel J.
Braat, Andries E. http://orcid.org/0000-0003-3615-2690
Crobach, Stijn http://orcid.org/0000-0002-1289-4406
van Delden, Otto M. http://orcid.org/0000-0003-3342-9367
Dibbets-Schneider, Petra http://orcid.org/0000-0003-0538-8270
van der Hulle, Tom http://orcid.org/0000-0002-2296-1828
Klümpen, Heinz-Josef http://orcid.org/0000-0002-7290-1823
van der Meer, Rutger W. http://orcid.org/0000-0001-7831-6986
Nijsen, J. Frank W. http://orcid.org/0000-0001-7625-2253
van Rijswijk, Catharina S. P. http://orcid.org/0000-0002-7958-6926
Roosen, Joey http://orcid.org/0000-0002-7965-6664
Ruijter, Bastian N. http://orcid.org/0000-0003-4737-4088
Smit, Frits http://orcid.org/0000-0003-2915-8613
Stam, Mette K.
Takkenberg, R. Bart http://orcid.org/0000-0003-2179-1385
Tushuizen, Maarten E. http://orcid.org/0000-0001-6342-9056
van Velden, Floris H. P. http://orcid.org/0000-0003-2859-2119
de Geus-Oei, Lioe-Fee http://orcid.org/0000-0003-1817-2743
Burgmans, Mark C. http://orcid.org/0000-0001-5258-291X
,
Funding for this research was provided by:
Health~Holland (40-41200-98-9286)
Article History
Received: 6 October 2023
Accepted: 27 January 2024
First Online: 8 February 2024
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Committee of Medical Ethics of the Leiden University Medical Center (Date: 18-01-2018; Number P17.161).
: Informed consent was obtained from all individual participants included in the study.
: The authors affirm that human research participants provided informed consent for publication of the images in Figs. InternalRef removed and InternalRef removed.
: M.C. Burgmans has received an educational grant from Boston Scientific and Medtronic and consultancy fees from SIRTeX, Medtronic, Delcath Systems, and Philips Health Care. None are related to the current project. J.F.W. Nijsen is co-founder of Quirem Medical, which has been acquired by Terumo Europe NV in July 2020. Nijsen has a scientific advisory role and is entitled to certain milestone payments from Terumo, which are related to Quirem’s financial, operational, and regulatory performance in the future. Furthermore, Nijsen is inventor on the patents related to radioactive microspheres that are assigned to University Medical Center Utrecht Holding BV, Quirem Medical, or BASF Corp. The activities of J.F.W. Nijsen within Quirem Medical are approved and supported by the Board of Directors of the Radboudumc. All other authors declare that they have no conflict of interest.